308 related articles for article (PubMed ID: 29734195)
21. Transforming growth factor-β (TGF-β) pathway abnormalities in tenascin-X deficiency associated with CAH-X syndrome.
Morissette R; Merke DP; McDonnell NB
Eur J Med Genet; 2014 Feb; 57(2-3):95-102. PubMed ID: 24380766
[TBL] [Abstract][Full Text] [Related]
22. Recognizing the tenascin-X deficient type of Ehlers-Danlos syndrome: a cross-sectional study in 17 patients.
Demirdas S; Dulfer E; Robert L; Kempers M; van Beek D; Micha D; van Engelen BG; Hamel B; Schalkwijk J; Loeys B; Maugeri A; Voermans NC
Clin Genet; 2017 Mar; 91(3):411-425. PubMed ID: 27582382
[TBL] [Abstract][Full Text] [Related]
23. Revisiting the association of HLA alleles and haplotypes with CYP21A2 mutations in a large cohort of patients with congenital adrenal hyperplasia.
Jayakrishnan R; Lao Q; Adams SD; Ward WW; Merke DP
Gene; 2019 Mar; 687():30-34. PubMed ID: 30419250
[TBL] [Abstract][Full Text] [Related]
24. Clinical and Molecular Characterization of Classical-Like Ehlers-Danlos Syndrome Due to a Novel
Rymen D; Ritelli M; Zoppi N; Cinquina V; Giunta C; Rohrbach M; Colombi M
Genes (Basel); 2019 Oct; 10(11):. PubMed ID: 31731524
[TBL] [Abstract][Full Text] [Related]
25. Complement component 4 copy number variation and CYP21A2 genotype associations in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Chen W; Xu Z; Nishitani M; Van Ryzin C; McDonnell NB; Merke DP
Hum Genet; 2012 Dec; 131(12):1889-94. PubMed ID: 22886582
[TBL] [Abstract][Full Text] [Related]
26. Measurement of Serum Tenascin-X in Joint Hypermobility Syndrome Patients.
Yamada K; Watanabe A; Takeshita H; Fujita A; Miyake N; Matsumoto N; Matsumoto KI
Biol Pharm Bull; 2019; 42(9):1596-1599. PubMed ID: 31474720
[TBL] [Abstract][Full Text] [Related]
27. A rare CYP21A2 mutation in a congenital adrenal hyperplasia kindred displaying genotype-phenotype nonconcordance.
Khattab A; Yuen T; Al-Malki S; Yau M; Kazmi D; Sun L; Harbison M; Haider S; Zaidi M; New MI
Ann N Y Acad Sci; 2016 Jan; 1364(1):5-10. PubMed ID: 26291314
[TBL] [Abstract][Full Text] [Related]
28. Tenascin-X deficiency is associated with Ehlers-Danlos syndrome.
Burch GH; Gong Y; Liu W; Dettman RW; Curry CJ; Smith L; Miller WL; Bristow J
Nat Genet; 1997 Sep; 17(1):104-8. PubMed ID: 9288108
[TBL] [Abstract][Full Text] [Related]
29. Chimeric CYP21P/CYP21 and TNXA/TNXB genes in the RCCX module.
Lee HH
Mol Genet Metab; 2005 Jan; 84(1):4-8. PubMed ID: 15639189
[TBL] [Abstract][Full Text] [Related]
30. Response to Letter to the Editor from Lao and Merke: "Ehlers-Danlos Syndrome: Molecular and Clinical Characterization of TNXA/TNXB Chimeras in Congenital Adrenal Hyperplasia".
Marino R; Perez Garrido N; Ramirez P; Belgorosky A
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2837-e2838. PubMed ID: 33901286
[No Abstract] [Full Text] [Related]
31. Letter to the Editor from Lao and Merke: "Ehlers-Danlos Syndrome: Molecular and Clirnical Characterization of TNXA/TNXB Chimeras in Congenital Adrenal Hyperplasia".
Lao Q; Merke DP
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2835-e2836. PubMed ID: 33901292
[No Abstract] [Full Text] [Related]
32. A novel role for the extracellular matrix glycoprotein-Tenascin-X in gastric function.
Aktar R; Peiris M; Fikree A; Eaton S; Kritas S; Kentish SJ; Araujo EJA; Bacarin C; Page AJ; Voermans NC; Aziz Q; Blackshaw LA
J Physiol; 2019 Mar; 597(6):1503-1515. PubMed ID: 30605228
[TBL] [Abstract][Full Text] [Related]
33. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
[TBL] [Abstract][Full Text] [Related]
34. Genes and Pseudogenes: Complexity of the RCCX Locus and Disease.
Carrozza C; Foca L; De Paolis E; Concolino P
Front Endocrinol (Lausanne); 2021; 12():709758. PubMed ID: 34394006
[TBL] [Abstract][Full Text] [Related]
35. [Vascular Calcification - Pathological Mechanism and Clinical Application - . Extracellular matrix tenascin-X in calcific aortic valves].
Matsumoto K
Clin Calcium; 2015 May; 25(5):701-10. PubMed ID: 25926574
[TBL] [Abstract][Full Text] [Related]
36. Congenital adrenal hyperplasia, ovarian failure and Ehlers-Danlos syndrome due to a 6p deletion.
Moysés-Oliveira M; Mancini TI; Takeno SS; Rodrigues AD; Bachega TA; Bertola D; Melaragno MI
Sex Dev; 2014; 8(4):139-45. PubMed ID: 24970489
[TBL] [Abstract][Full Text] [Related]
37. Phenotypic effects of Ehlers-Danlos syndrome-associated mutation on the FnIII domain of tenascin-X.
Zhuang S; Linhananta A; Li H
Protein Sci; 2010 Oct; 19(11):2231-9. PubMed ID: 20853426
[TBL] [Abstract][Full Text] [Related]
38. Congenital Adrenal Hyperplasia (CAH) due to 21-Hydroxylase Deficiency: A Comprehensive Focus on 233 Pathogenic Variants of CYP21A2 Gene.
Concolino P; Costella A
Mol Diagn Ther; 2018 Jun; 22(3):261-280. PubMed ID: 29450859
[TBL] [Abstract][Full Text] [Related]
39. A new CYP21A2 nonsense mutation causing severe 21-hydroxylase deficiency.
Concolino P; Minucci A; Mello E; Zuppi C; Capoluongo E
Clin Chem Lab Med; 2009; 47(7):824-5. PubMed ID: 19499972
[TBL] [Abstract][Full Text] [Related]
40. Novel
Micale L; Guarnieri V; Augello B; Palumbo O; Agolini E; Sofia VM; Mazza T; Novelli A; Carella M; Castori M
Genes (Basel); 2019 Nov; 10(12):. PubMed ID: 31775249
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
